Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Altmann

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 24, 2005
Increase in daytime symptoms is a sensitive and specific criterion for predicting corticosteroid-treated exacerbations in a clinical asthma trialS M Dennis, D R Altmann, T H Lee
Clinical Pharmacology and Therapeutics|March 9, 2012
Advances in imaging to support the development of novel therapies for multiple sclerosisD H Miller, D R Altmann, D T Chard
Addiction (Abingdon, England)|January 11, 2002
Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic reviewG Mazzaglia, A R Britton, D R Altmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 23, 2005
Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivityL J Cormican, S Farooque, D R Altmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2005
The corpus callosum in first episode schizophrenia: a diffusion tensor imaging studyG Price, M S Bagary, M Cercignani, et al.
Neuropathology and Applied Neurobiology|April 19, 2017
Neuronal loss, demyelination and volume change in the multiple sclerosis neocortexD Carassiti, D R Altmann, N Petrova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypesD Soon, D J Tozer, D R Altmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2009
MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunctionV M Anderson, L K Fisniku, D R Altmann, et al.
Magnetic Resonance in Medicine|May 21, 2005
Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysisD J Tozer, G R Davies, D R Altmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 24, 2003
Corticosteroids do not prevent optic nerve atrophy following optic neuritisS J Hickman, R Kapoor, S J Jones, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 24, 2005
Increase in daytime symptoms is a sensitive and specific criterion for predicting corticosteroid-treated exacerbations in a clinical asthma trialS M Dennis, D R Altmann, T H Lee
Clinical Pharmacology and Therapeutics|March 9, 2012
Advances in imaging to support the development of novel therapies for multiple sclerosisD H Miller, D R Altmann, D T Chard
Addiction (Abingdon, England)|January 11, 2002
Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic reviewG Mazzaglia, A R Britton, D R Altmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 23, 2005
Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivityL J Cormican, S Farooque, D R Altmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2005
The corpus callosum in first episode schizophrenia: a diffusion tensor imaging studyG Price, M S Bagary, M Cercignani, et al.
Neuropathology and Applied Neurobiology|April 19, 2017
Neuronal loss, demyelination and volume change in the multiple sclerosis neocortexD Carassiti, D R Altmann, N Petrova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypesD Soon, D J Tozer, D R Altmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2009
MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunctionV M Anderson, L K Fisniku, D R Altmann, et al.
Magnetic Resonance in Medicine|May 21, 2005
Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysisD J Tozer, G R Davies, D R Altmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 24, 2003
Corticosteroids do not prevent optic nerve atrophy following optic neuritisS J Hickman, R Kapoor, S J Jones, et al.
Pageof 5